ClotProtect Therapeutics
PrivateLast Round
Seed
Feb 18, 2026
Total Funding Raised
$1.62M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
ClotProtect Therapeutics is a biotechnology company that develops small molecule anti-fibrinolytic agents for the treatment of acute hemorrhage and traumatic bleeding.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ClotProtect Therapeutics Comparables
Compare ClotProtect Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lunac Therapeutics | 88% | |
| Coagulant Therapeutics Corporation | 54% | |
| Cayuga Biotech | 53% | |
ClotProtect Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 18, 2026 | ||||
| Pre Seed | Apr 22, 2024 |
ClotProtect Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| University of Leeds | Pre Seed |
| Lifted Ventures | Seed |
| o2h ventures | Pre Seed |
| Innovate UK | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 18, 2026
$1.6M round led by Lifted Ventures.
- Apr 22, 2024
Led by o2h ventures with participation from University of Leeds.
ClotProtect Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ClotProtect Therapeutics's valuation, stock price, and market status.